FI883337L - Icke-vattenloesningar av doxorubicinhydroklorin. - Google Patents

Icke-vattenloesningar av doxorubicinhydroklorin. Download PDF

Info

Publication number
FI883337L
FI883337L FI883337A FI883337A FI883337L FI 883337 L FI883337 L FI 883337L FI 883337 A FI883337 A FI 883337A FI 883337 A FI883337 A FI 883337A FI 883337 L FI883337 L FI 883337L
Authority
FI
Finland
Prior art keywords
vattenloesningar
hydrochlorin
icke
doxorubicin
doxorubicin hydrochlorin
Prior art date
Application number
FI883337A
Other languages
English (en)
Finnish (fi)
Other versions
FI883337A0 (fi
FI883337A7 (fi
Inventor
Murray Arthur Kaplan
Joseph Ballard Bogardus
Robert Kevin Perrone
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of FI883337A0 publication Critical patent/FI883337A0/fi
Publication of FI883337A7 publication Critical patent/FI883337A7/fi
Publication of FI883337L publication Critical patent/FI883337L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI883337A 1987-07-16 1988-07-13 Icke-vattenloesningar av doxorubicinhydroklorin. FI883337L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7418987A 1987-07-16 1987-07-16

Publications (3)

Publication Number Publication Date
FI883337A0 FI883337A0 (fi) 1988-07-13
FI883337A7 FI883337A7 (fi) 1989-01-17
FI883337L true FI883337L (fi) 1989-01-17

Family

ID=22118210

Family Applications (1)

Application Number Title Priority Date Filing Date
FI883337A FI883337L (fi) 1987-07-16 1988-07-13 Icke-vattenloesningar av doxorubicinhydroklorin.

Country Status (11)

Country Link
EP (1) EP0299528B1 (pt)
JP (1) JPS6438021A (pt)
KR (1) KR920004096B1 (pt)
AT (1) ATE82682T1 (pt)
AU (1) AU615454B2 (pt)
DE (1) DE3876160T2 (pt)
DK (1) DK396188A (pt)
ES (1) ES2052646T3 (pt)
FI (1) FI883337L (pt)
GR (1) GR3006383T3 (pt)
PT (1) PT88015B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0372889B1 (en) * 1988-12-05 1993-03-24 Bristol-Myers Squibb Company Doxorubicin solutions
FR2690340B1 (fr) * 1992-04-24 1995-02-24 Scr Newmed Nouveau procédé de stabilisation des préparations pharmaceutiques liquides et les compositions pharmaceutiques ainsi stabilisées en résultant.
RU2065307C1 (ru) * 1994-12-13 1996-08-20 Александр Васильевич Тихонов Способ лечения первичного рака печени и набор для лечения первичного рака печени
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US5946961A (en) * 1998-05-01 1999-09-07 Buhrke Industries, Inc. Web bowing apparatus
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6071952A (en) * 1998-12-02 2000-06-06 Mylan Pharmaceuticals, Inc. Stabilized injectable pharmaceutical compositions containing taxoid anti-neoplastic agents
RU2134589C1 (ru) * 1998-12-22 1999-08-20 Зубов Дмитрий Львович Способ лечения первичного рака печени и набор для лечения первичного рака печени
JP2015523401A (ja) * 2012-08-03 2015-08-13 メステックス・アー・ゲー レシニフェラトキシン溶液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795492B (en) * 1978-10-20 1981-05-27 Lilly Co Eli Stable erythromycin solution
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure

Also Published As

Publication number Publication date
PT88015B (pt) 1995-03-01
ATE82682T1 (de) 1992-12-15
FI883337A0 (fi) 1988-07-13
DE3876160D1 (de) 1993-01-07
EP0299528B1 (en) 1992-11-25
EP0299528A1 (en) 1989-01-18
DK396188A (da) 1989-01-17
PT88015A (pt) 1989-06-30
KR920004096B1 (ko) 1992-05-25
AU615454B2 (en) 1991-10-03
FI883337A7 (fi) 1989-01-17
ES2052646T3 (es) 1994-07-16
AU1905188A (en) 1989-01-19
JPH0559093B2 (pt) 1993-08-30
KR890001570A (ko) 1989-03-27
GR3006383T3 (pt) 1993-06-21
DK396188D0 (da) 1988-07-15
DE3876160T2 (de) 1993-04-01
JPS6438021A (en) 1989-02-08

Similar Documents

Publication Publication Date Title
FI871488A7 (fi) Fibreringsanordning foer framstaellning av mineralull.
FI883338L (fi) Vattenloesningar av doxorubicinhydroklorid.
FI872001L (fi) Anordning foer sammanfogning av tvao byggnadselement.
FI870360A0 (fi) Nytt foerfarande foer framstaellning av natriumkarboximetylcellulosa.
FI870963A0 (fi) Foerfarande foer plantering av plantor.
FI870122A0 (fi) Konjugat av biologiska molekyler.
FI883508L (fi) Foerfarande foer framstaellning av nytt diosminderivat.
FI871566A0 (fi) Regleringsanordning foer ytbehandlingsanordning av materialbana.
FI870820A0 (fi) Foerfarande foer fraktionering av avlutar fraon alkaliska massakok.
FI870229A0 (fi) Anordning foer bestaemning av en pappersmassas filtreringsfoermaoga.
FI870781A0 (fi) Blandning foer framstaellning av kemiskt haollfast betong.
FI871153A0 (fi) Anordning foer vertikalkvistning av traed.
FI871581A0 (fi) Anordning foer installering av uppraett taeckdike.
FI870605L (fi) Foerfarande foer framstaellning av en tryckgivarfiber.
FI871783L (fi) Foerfarande foer avlaegsnande av latenta egenskaper.
FI871008A0 (fi) Anordning foer matning av djur.
FI871797A0 (fi) Foerfarande foer gjutning av skalyta.
FI870741A0 (fi) Anordning foer utbyte av foerpackningslaoda.
FI870635A0 (fi) Foerfarande foer balansering av ramsaog.
FI870395A0 (fi) Foerfarande foer framstaellning av laminerad vaeggkonstruktion.
FI870514A0 (fi) Laminering av glasrutor.
FI871677L (fi) Foerfarande foer behandling av problemavfall.
FI871678A0 (fi) Hydrerkrackningskatalyt foer framstaellning av mittendestillat.
FI871803A0 (fi) Anlaeggning foer utforming av en laoda fraon laodaemne.
FI871775A0 (fi) Foerfarande foer uppsamling av olja fraon vatten.

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: BRISTOL-MYERS SQUIBB COMPANY